|
|
|
|
LEADER |
01304nab a2200361 i 4500 |
001 |
publ12011 |
005 |
20200214114724.0 |
008 |
170928s2017 hu o 0|| zxx d |
022 |
|
|
|a 1873-9946
|
024 |
7 |
|
|a 10.1093/ecco-jcc/jjw203
|2 doi
|
024 |
7 |
|
|a 3140312
|2 mtmt
|
040 |
|
|
|a SZTE Publicatio Repozitórium
|b hun
|
041 |
|
|
|a zxx
|
100 |
1 |
|
|a Gönczi Lóránt
|
245 |
1 |
0 |
|a Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?
|h [elektronikus dokumentum] /
|c Gönczi Lóránt
|
260 |
|
|
|c 2017
|
300 |
|
|
|a 697-705
|
490 |
0 |
|
|a JOURNAL OF CROHNS & COLITIS
|v 11 No. 6
|
700 |
0 |
1 |
|a Végh Zsuzsanna
|e aut
|
700 |
0 |
1 |
|a Golovics Petra Anna
|e aut
|
700 |
0 |
1 |
|a Rutka Mariann
|e aut
|
700 |
0 |
1 |
|a Gecse Krisztina Barbara
|e aut
|
700 |
0 |
1 |
|a Bor Renáta
|e aut
|
700 |
0 |
1 |
|a Farkas Klaudia
|e aut
|
700 |
0 |
1 |
|a Szamosi Tamás
|e aut
|
700 |
0 |
1 |
|a Bene László
|e aut
|
700 |
0 |
1 |
|a Gasztonyi Beáta
|e aut
|
700 |
0 |
1 |
|a Kristóf Tünde
|e aut
|
700 |
0 |
1 |
|a Lakatos László
|e aut
|
700 |
0 |
1 |
|a Miheller Pál
|e aut
|
700 |
0 |
1 |
|a Palatka Károly
|e aut
|
700 |
0 |
1 |
|a Papp Mária
|e aut
|
856 |
4 |
0 |
|u http://publicatio.bibl.u-szeged.hu/12011/1/3140312_Gonczi.pdf
|z Dokumentum-elérés
|